Table 4.
Association between maximal CD3 expression in biopsy and urine levels of chemokines adjusted for age and treatment
| Variable | N | β* | p value |
|---|---|---|---|
| CCL2 | 107 | −0.03 | 0.59 |
| CCL3 | 15 | 0.13 | 0.77 |
| CCL5 | 89 | −0.07 | 0.22 |
| CXCL1 | 105 | 0.01 | 0.80 |
| CXCL8 | 105 | 0.02 | 0.72 |
| CXCL10 | 96 | −0.05 | 0.27 |
| IL6 | 74 | −0.03 | 0.60 |
| IL1RA | 107 | 0.07 | 0.12 |
| PDGF-BB | 86 | 0 | 0.97 |
| sCD40L | 46 | −0.02 | 0.81 |
Urine levels of CCL5 were associated with maximal CD3 expression.
*
Linear regression modelling employed CD3 as the response and the urinary chemokine as the primary covariate to calculate β coefficient adjusted for age and BPH treatment